Remove Homecare Remove In-home health Remove Medicare
article thumbnail

Addus Orients M&A Strategy Away From Hospice, Towards Home Health, Personal Care

Hospice News

Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its home health and personal care businesses. Texas-based Addus provides personal, home health and hospice care across 207 locations in 22 states, reaching roughly 46,500 patients annually.

article thumbnail

Hospice M&A Going Strong, But Non-Medical Home Care a Rising Star

Hospice News

Deal volume for non-medical home care companies outstripped that for hospice or home health during the first half of the year. As of the end of Q2, this included 23 deals compared to 17 each for Medicare-certified home health and for hospice, according to a report by M&A advisory firm Mertz Taggart.

Home care 264
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Addus Acquires Apple Home Healthcare

Hospice News

Addus HomeCare Corporation (NASDAQ: ADUS) has acquired Chicago-based Apple Home Healthcare, Ltd., The state is one of three in which Addus offers its trifecta of business lines — personal care, home health and hospice. The previous year Addus bought Chicago-based Summit Home Health for an undisclosed amount.

article thumbnail

How Home Health, Personal Care Reimbursement Guiding Addus’ M&A Strategy

Hospice News

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.

article thumbnail

How Proposed Cuts to Home Health Payments Could Impact Hospice M&A

Hospice News

Disruption in home health reimbursement has an influence on the hospice mergers and acquisitions market, particularly among the rising number of companies offering both services. NASDAQ: AMED), and Addus Homecare (NASDAQ: ADUS) indicated that they would prioritize home health deals this year.

2026 246
article thumbnail

How the 2023 Home Health Rule Could Change the Game in Hospice M&A

Hospice News

The pendulum of investor interest has swung hard into the hospice market in recent years, but shifts in reimbursement could steer buyers towards home health. Uncertainty earlier this year around Medicare’s proposed 2023 home health payment rates led some stakeholders to expect a swerve towards hospice.

2023 189
article thumbnail

5 Most Game-Changing Hospice Deals from 2022

Hospice News

Humana’s two Kindred at Home transactions added notches to the company’s belt as it expands its value-based care portfolio as both a provider and payer. The divestiture fits into Humana’s stated goal of raising its enterprise value by $1 billion , while building out its health care services and Medicare Advantage business.

2022 246